Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH PANACEA BIOTECH PROCTER & GAMBLE HEALTH/
PANACEA BIOTECH
 
P/E (TTM) x 34.4 -60.5 - View Chart
P/BV x 10.5 0.9 1,201.1% View Chart
Dividend Yield % 2.0 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   PANACEA BIOTECH
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
PANACEA BIOTECH
Mar-23
PROCTER & GAMBLE HEALTH/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs5,366191 2,804.1%   
Low Rs3,883107 3,623.9%   
Sales per share (Unadj.) Rs740.775.1 986.4%  
Earnings per share (Unadj.) Rs138.2-5.5 -2,509.1%  
Cash flow per share (Unadj.) Rs155.20.9 17,671.5%  
Dividends per share (Unadj.) Rs95.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs447.6137.7 325.0%  
Shares outstanding (eoy) m16.6061.25 27.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.22.0 314.1%   
Avg P/E ratio x33.5-27.1 -123.5%  
P/CF ratio (eoy) x29.8170.0 17.5%  
Price / Book Value ratio x10.31.1 953.3%  
Dividend payout %68.70-   
Avg Mkt Cap Rs m76,7619,142 839.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0621,265 163.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,2964,599 267.3%  
Other income Rs m184517 35.6%   
Total revenues Rs m12,4805,116 243.9%   
Gross profit Rs m3,24747 6,905.1%  
Depreciation Rs m281391 71.8%   
Interest Rs m844 17.4%   
Profit before tax Rs m3,142128 2,453.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m847466 182.0%   
Profit after tax Rs m2,295-337 -680.0%  
Gross profit margin %26.41.0 2,582.9%  
Effective tax rate %27.0363.5 7.4%   
Net profit margin %18.7-7.3 -254.4%  
BALANCE SHEET DATA
Current assets Rs m11,7135,623 208.3%   
Current liabilities Rs m6,7913,297 205.9%   
Net working cap to sales %40.050.6 79.2%  
Current ratio x1.71.7 101.1%  
Inventory Days Days26359 447.6%  
Debtors Days Days34348 720.3%  
Net fixed assets Rs m10,6177,028 151.1%   
Share capital Rs m16661 271.0%   
"Free" reserves Rs m7,2658,375 86.7%   
Net worth Rs m7,4318,436 88.1%   
Long term debt Rs m0202 0.0%   
Total assets Rs m22,33012,712 175.7%  
Interest coverage x409.13.9 10,526.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.4 152.2%   
Return on assets %10.3-2.3 -447.2%  
Return on equity %30.9-4.0 -772.0%  
Return on capital %42.42.0 2,123.5%  
Exports to sales %043.3 0.0%   
Imports to sales %13.124.4 53.4%   
Exports (fob) Rs mNA1,992 0.0%   
Imports (cif) Rs m1,6051,124 142.9%   
Fx inflow Rs m1,4651,992 73.5%   
Fx outflow Rs m1,6051,191 134.8%   
Net fx Rs m-140801 -17.5%   
CASH FLOW
From Operations Rs m2,360-4,225 -55.9%  
From Investments Rs m-2154,303 -5.0%  
From Financial Activity Rs m-985-184 535.9%  
Net Cashflow Rs m1,160-105 -1,105.3%  

Share Holding

Indian Promoters % 0.0 73.6 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 1.0 2,132.6%  
FIIs % 7.6 0.3 2,923.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 26.4 182.4%  
Shareholders   56,730 47,091 120.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Panacea Biotech Share Price Performance

Period Procter & Gamble Health Panacea Biotech S&P BSE HEALTHCARE
1-Day -0.69% -2.47% 1.18%
1-Month -7.59% -20.61% -0.75%
1-Year -3.15% 10.92% 61.82%
3-Year CAGR -9.16% -12.48% 18.16%
5-Year CAGR 5.72% -10.11% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.